Antineoplastics, Newer

• Oncology - Feb 03, 2022
• Oncology - Oct 07, 2021
• Oncology - Jun 03, 2021

• Oncology - Feb 04, 2021
• Oncology proposal - Jun 04, 2020

• Newer Oncology Agents - Apr 03, 2025

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.